巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Cryo-Cell International

    CCEL
    5.750
    0.260
    4.74%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Cryo-Cell International - 延遲價格・最後更新於 10/08 9:30
    最高位
    5.750
    最低位
    5.750
    開市價
    --
    前收市價
    5.490
    成交量(千)
    0.00
    成交額(百萬)
    0.00
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    48.23
    市盈率
    30.260
    息率
    --
    差價
    --
    52週高低
    14.160 - 5.000
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Cryo-Cell International
    證券代碼
    CCEL.US
    所屬板塊
    Medical Care Facilities
    公司業務
    Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. It is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
    發行量
    8460380
    公司總部
    700 Brooker Creek Boulevard, Suite 1800
    公司網址
    https://www.cryo-cell.com
    公司電話
    +1 813 749-2100
    暫無內容

    關於

    Cryo-Cell International(CCEL.US)所屬的行業板塊為Medical Care Facilities。
    Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. It is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group functions through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.
    詳細公司背景可參考: https://www.cryo-cell.com